[Skip to Content]

Upstate Active Clinical Trials

Study Title:

TrialNet Natural History Study of the Development of Type 1 Diabetes (Pathway to Prevention)

What is the purpose of the study? (in Layman's terms, please describe the study)

The specific purpose of the TrialNet Natural History Study of the Development of Type 1 Diabetes is to learn more about how type 1 diabetes occurs. Relatives of people with type 1 diabetes have a 10 to 15 times greater risk for the disease than people with no family history. Because of this, we are screening close blood relatives of people with type 1 diabetes. This includes brothers, sisters, parents, children, cousins, aunts, uncles, and grandchildren of people with type 1 diabetes. The study is divided into three phases: Screening (Phase 1), Baseline Risk Assessment (Phase 2), and Follow-Up Risk Assessments (Phase 3). This consent form will tell you about Phase 1 in detail. The screening phase of the study (Phase 1) will include testing for diabetes related autoantibodies in the blood. Autoantibodies are proteins that are made by the bodys immune system. If these proteins are present, it could mean that cells in the pancreas that produce insulin are damaged. Autoantibodies can be found in the blood years before type 1 diabetes occurs. Several different kinds of autoantibodies can be seen.Individuals found to have autoantibodies in Phase 1 will qualify for Phases 2 and 3. Phase 2 would require one visit for most participants. Phase 3 would require a visit every six months for up to five years or until the end of the study. Blood tests will be performed at the Phase 2 and Phase 3 visits in order to find out more about your risk for type 1 diabetes.

Upstate Institutional Review Board (IRB) Number:

226718

Study/Protocol ID:

TN-01

Study Phase:

N/A

Patient Age Group:

Adults and Children

Principal Investigator:

David Hansen, MD

What is involved if I participate?

  • How long is the study?
    up to 5 years
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Screening blood work to test for the presence of autoantibodies.

Where will the study take place?

The Clinical Research Unit at the Institute for Human Performance

Other Information:

There is no compensation for participating in this study.

ClinicalTrials.Gov ID:

NCTN/A

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Lynn M Agostini, AAS
Phone: 315-464-8237
Email: [email protected]

Return to Previous Page || Search Again

Top